Journal profile · Medicine, Research & Experimental

CTS-Clinical and Translational Science

ISSN 1752-8054 · eISSN 1752-8062 · Wiley-Blackwell Publishing Ltd · UNITED STATES · Bimonthly · Founded 2008

CTS-Clinical and Translational Science: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.23; fully open access; APC about USD 3,990; median 105 days to acceptance (104 articles, last 24 months); community-reported acceptance: fairly easy; 370 articles in 2025; indexed in SCIE and Scopus.

Impact factor4.23Latest value listed by LetPub
CAS zoneZone 3 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 3 · Medicine
Review time105 daysMedian, submission to acceptance · 104 articles, last 24 months · Crossref
APCUSD 3,990Fully open access
AcceptanceFairly easyCommunity average
Articles per year3702025 · OpenAlex count

Scope

Aims, scope and focus

CTS-Clinical and Translational Science is published by Wiley-Blackwell Publishing Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Health and Medical Research Impacts, Pharmacogenetics and Drug Metabolism and Health Systems, Economic Evaluations, Quality of Life, together about 31.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

<em>Clinical and Translational Science</em> is an open access translational research journal combining laboratory discoveries with the diagnosis and treatment of human disease.

From the journal's Aims & Scope

Research area (LetPub): Medicine, Research & Experimental

Editor-in-chief John A. WagnerPublisher website

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Health and Medical Research ImpactsMedicine11.6%
  2. Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics10.6%
  3. Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance9.4%
  4. Statistical Methods in Clinical TrialsMathematics5.3%
  5. Pharmaceutical studies and practicesMedicine4.8%
  6. Ethics in Clinical ResearchMedicine4.7%
  7. Drug Transport and Resistance MechanismsMedicine4.4%
  8. Biomedical Ethics and RegulationMedicine3.9%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorMedicine, Research & ExperimentalZone 3

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorMedicine, Research & ExperimentalZone 3

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorMedicine, Research & ExperimentalZone 3

Top journal: noReview journal: no

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
4.23LetPub ·
Impact factor (publisher) 2025
4.3Publisher website ·
CiteScore 2026-06
5.4LetPub ·
CiteScore (publisher) 2025
5.4Publisher website ·
SJR 2026-06
1.19LetPub ·
SNIP 2026-06
1.08LetPub ·
h-index
35LetPub ·
h-index
85OpenAlex ·
i10-index
1,272OpenAlex ·
2-year mean citedness
5OpenAlex ·
Self-citation rate
4.7%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
333LetPub ·
Articles per year (publisher) 2025
342Publisher website ·
Downloads per year (publisher) 2025
1,091,455Publisher website ·

Articles by year OpenAlex count · 3,287 in total · the current year is incomplete

YearArticlesOpen accessCitations
202628228282
20253703701,295
20243293293,530
20232502502,871
20222572573,489
20212492494,967

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

105 daysMedian, submission to acceptance · P25–P75 75 days – 150 days

Acceptance to online
median 22 days (104 articles)
Submission to online
median 133 days
Sample
104 articles with submission and acceptance dates (712 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
6–12 weeksLetPub ·
Average acceptance (community reports)
Fairly easyLetPub ·
Acceptance rate (publisher) 2025
48%Publisher website ·
Submission to first decision 2025
32 daysPublisher website ·
Submission to acceptance 2025
100 daysPublisher website ·
Acceptance to publication 2025
24 daysPublisher website ·
Submission to publication (journal-reported)
about 10 weeksDOAJ ·
Peer review
Unspecified peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 3,990 / GBP 3,030 / EUR 3,400YesCC BY, CC BY-NC, CC BY-NC-ND
OpenAlexUSD 3,630 / EUR 3,090 / GBP 2,760——
LetPubUSD 3,300 / GBP 4,500 / EUR 3,800Yes—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Wiley-Blackwell Publishing Ltd
Country or region
UNITED STATES
Language
English
Frequency
Bimonthly
Founded
2008
ISSN
1752-8054
Electronic ISSN
1752-8062
Latest issue on the website
Volume 19, Issue 10 (October 2026)
Official links

FAQ

Frequently asked questions about CTS-Clinical and Translational Science

What CAS zone is CTS-Clinical and Translational Science in?

In the 2025 upgraded edition of the CAS Journal Ranking, CTS-Clinical and Translational Science is in Zone 3 of Medicine, and in Zone 3 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of CTS-Clinical and Translational Science?

The latest impact factor listed by LetPub is 4.23; CiteScore 5.4, h-index 85.

How long does peer review take at CTS-Clinical and Translational Science?

Based on the dates recorded on 104 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 105 days (interquartile range 75–150 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 48% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index CTS-Clinical and Translational Science?

According to LetPub and DOAJ records, CTS-Clinical and Translational Science is indexed in SCIE, Scopus and DOAJ.

Is CTS-Clinical and Translational Science open access, and what is the APC?

CTS-Clinical and Translational Science is a fully open-access journal. APC about USD 3,990.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .